ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2247

Secondary Fibromyalgia Is Not Associated with Higher Likelihood of Patient-Physician Discordance in Global Assessment in Patients with Osteoarthritis and Rheumatoid Arthritis

Isabel Castrejón, Shakeel M. Jamal and Najia Shakoor, Division of Rheumatology, Rush University Medical Center, Chicago, IL

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: fibromyalgia, Osteoarthritis, patient outcomes and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Patient Outcomes, Preferences, and Attitudes Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Pain is the strongest driver of patient-physician discordance in global assessment in patients with rheumatoid arthritis (RA) and osteoarthritis (OA). Having secondary fibromyalgia (FM), a disorder with vague and nonspecific symptoms (e.g., widespread body pain or fatigue) may increase the likelihood of discordance. We aim to analyze if patients with RA and OA presenting with secondary FM have higher likelihood of discordance.

Methods: All patients complete a multidimensional health assessment questionnaire (MDHAQ) as part of their routine care which includes scores for physical function, pain, PATGL, fatigue, and demographic data. Rheumatologists complete a RheuMetric including 4 visual analogue scales: a physician global assessment (DOCGL) and three subscales for inflammation, damage, and distress/FM. A mean difference PATGL-DOCGL ≥2cm was considered a relevant discordance. Patients with a clinical diagnoses of OA or RA were classified into 3 categories: PATGL ≥ DOCGL by 2/10 units, PATGL = DOCGL, and DOCGL ≥ PATGL by 2 units. Secondary FM was evaluated using two criteria: 1) clinical diagnosis by the treating rheumatologist. 2) A score ≥6 in the VAS for distress/FM. The percentage of patients in each group was compared using chi-square.

Results: 243 OA and 216 RA patients were included. Patients with OA were older and showed higher scores for PATGL, pain, and fatigue (data not showed) and higher level of discordance (PATGL>DOCGL) in comparison with RA (34% vs 18%, p<0.001). A higher percentage of patients with OA showed secondary FM (15% versus 3%, p<0.001) and a VAS for distress ≥6 (12% versus 5%, p=0.01) in comparison with patients with RA. Patients with OA and secondary FM have higher level of concordance (PATGL=DOCGL) in comparison with patients with OA without secondary FM (Table). There were no significant differences in the RA patients group when comparing patients with and without secondary FM (Table).

Table. Level of discordance/concordance in patients with or without secondary FM with OA or RA

OSTEOARTHRITIS

RHEUMATOID ARTHRITIS

Discordance groups, no. (%)

No Secondary FM

207 (85%)

Secondary FM

36 (15%)

p

No Secondary FM

210 (97%)

Secondary FM

6 (3%)

p

PATGL>DOCGL

72 (35%)

10 (28%)

0.03

37 (18%)

2 (33%)

0.58

PATGL=DOCGL

110 (53%)

26 (72%)

141 (67%)

3 (50%)

PATGL<DOCGL

25 (12%)

0 (0%)

32 (15%)

1 (17%)

Distress VAS<6

184 (88%)

Distress VAS≥6

24 (12%)

p

Distress VAS<6

188 (95%)

Distress VAS≥6

9 (5%)

p

PATGL>DOCGL

65 (35%)

5 (21%)

0.24

31 (16%)

0 (0%)

0.40

PATGL=DOCGL

97 (53%)

17 (71%)

127 (68%)

7 (78%)

PATGL<DOCGL

22 (12%)

2 (8%)

30 (16%)

2 (22%)

Conclusion: Patient-physician discordance is more prevalent in patients with OA versus RA. FM is also more prevalent in OA versus RA but the presence of FM does not account for the higher discordance rate. In fact, those with OA and FM appear to have more concordant scores with their physicians. The dual diagnoses of FM may make the physicians more sensitive to the pain of their patients.


Disclosure: I. Castrejón, None; S. M. Jamal, None; N. Shakoor, None.

To cite this abstract in AMA style:

Castrejón I, Jamal SM, Shakoor N. Secondary Fibromyalgia Is Not Associated with Higher Likelihood of Patient-Physician Discordance in Global Assessment in Patients with Osteoarthritis and Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/secondary-fibromyalgia-is-not-associated-with-higher-likelihood-of-patient-physician-discordance-in-global-assessment-in-patients-with-osteoarthritis-and-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/secondary-fibromyalgia-is-not-associated-with-higher-likelihood-of-patient-physician-discordance-in-global-assessment-in-patients-with-osteoarthritis-and-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology